Peripheral Vascular Disease in Diabetes

  • Sara B. Edwards
  • Jennifer K. SvahnEmail author
  • Jeffrey S. Kirk
  • Omar H. Llaguna
  • Nancy A. Habib
Reference work entry


Diabetes mellitus affects millions of Americans, incurs significant comorbidities, and costs billions annually in health-care dollars. Small and large vessel atherosclerotic changes contribute to coronary, cerebral, and peripheral vascular disease. Untreated macrovascular occlusion may result in loss of life or limb. However, multimodal management of this sequel may be achieved. The focus of this chapter’s discussion will be on the lower extremity peripheral vascular complications of diabetes including diagnosis, treatment, and new advancements in care.


Diabetes Mellitus Microvascular Macrovascular Peripheral Vascular Disease PVD Vascular Surgery Amputation Atherosclerosis Foot Ulcers Ankle-brachial index Angioplasty Bypass 


  1. 1.
    Villarroel MA, Vahratian A, Ward BW. Health care utilization among U.S. adults with diagnosed diabetes, 2013. NCHS Data Brief. 2015;(183):1–8.Google Scholar
  2. 2.
    Goldenberg S, Alex M, Joshi RA, Blumenthal HT. Nonatheromatous peripheral vascular disease of the lower extremity in diabetes mellitus. Diabetes. 1959;8(4):261–73.CrossRefPubMedGoogle Scholar
  3. 3.
    Barner HB, Kaiser GC, Willman VL. Blood flow in the diabetic leg. Circulation. 1971;43(3):391–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Conrad MC. Large and small artery occlusion in diabetics and nondiabetics with severe vascular disease. Circulation. 1967;36(1):83–91.CrossRefPubMedGoogle Scholar
  5. 5.
    Parving HH, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in the genesis of diabetic microangiopathy. Metab Clin Exp. 1983;32(9):943–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Flynn MD, Tooke JE. Aetiology of diabetic foot ulceration: a role for the microcirculation? Diabet Med. 1992;9(4):320–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med. 2014;370(16):1514–23.CrossRefPubMedGoogle Scholar
  8. 8.
    Yashkin AP, Picone G, Sloan F. Causes of the change in the rates of mortality and severe complications of diabetes mellitus: 1992–2012. Med Care. 2015;53(3):268–75.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Rayman G, Williams SA, Spencer PD, Smaje LH, Wise PH, Tooke JE. Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes. Br Med J. 1986;292(6531):1295–8.CrossRefGoogle Scholar
  10. 10.
    Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med. 1988;318(20):1306–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Hill RE, Williams PE. Perineurial cell basement membrane thickening and myelinated nerve fibre loss in diabetic and nondiabetic peripheral nerve. J Neurol Sci. 2004;217(2):157–63.CrossRefPubMedGoogle Scholar
  12. 12.
    Baron AD. The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes. 1996;45 Suppl 1:S105–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327(6122):524–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1998;31(3):552–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Wolff SP, Dean RT. Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation’ in diabetes. Biochem J. 1987;245(1):243–50.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Eton D, Weaver F, editors. Vascular disease: a multi-specialty approach to diagnosis and management. Austin: Landes Bioscience; 1998.Google Scholar
  17. 17.
    Ws M. Vascular surgery: a comprehensive review. 5th ed. Philadelphia: Saunders; 1997.Google Scholar
  18. 18.
    Muntner P, Wildman RP, Reynolds K, Desalvo KB, Chen J, Fonseca V. Relationship between HbA1c level and peripheral arterial disease. Diabetes Care. 2005;28(8):1981–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421–31.CrossRefPubMedGoogle Scholar
  20. 20.
    Loscalzo J, Creager M, Dzau VJ, editors. Vascular, medicine: a textbook of vascular biology and diseases. 2nd ed. Boston: Little, Brown; 1996.Google Scholar
  21. 21.
    Baker WH, String ST, Hayes AC, Turner D. Diagnosis of peripheral occlusive disease: comparison of clinical evaluation and noninvasive laboratory. Arch Surg. 1978;113(11):1308–10.CrossRefPubMedGoogle Scholar
  22. 22.
    Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation. 2002;105(7):816–22.CrossRefPubMedGoogle Scholar
  23. 23.
    Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran Jr LJ, et al. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2001;21(6):905–10.CrossRefPubMedGoogle Scholar
  24. 24.
    Malmstedt J, Karvestedt L, Swedenborg J, Brismar K. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study. Cardiovasc Diabetol. 2015;14:93.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109(21 Suppl 1):II27–33.PubMedGoogle Scholar
  26. 26.
    Koyama H, Yamamoto H, Nishizawa Y. Endogenous secretory RAGE as a novel biomarker for metabolic syndrome and cardiovascular diseases. Biomark Insights. 2007;2:331–9.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38(9):1777–803.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Suckow BD, Kraiss LW, Schanzer A, Stone DH, Kalish J, DeMartino RR, et al. Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival. J Vasc Surg. 2015;61(1):126–33.CrossRefPubMedGoogle Scholar
  29. 29.
    Mora S, Ridker PM. Justification for the use of statins in primary prevention: an intervention trial evaluating rosuvastatin (JUPITER) – can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol. 2006;97(2A):33A–41.CrossRefPubMedGoogle Scholar
  30. 30.
    Driver VR, Madsen J, Goodman RA. Reducing amputation rates in patients with diabetes at a military medical center: the limb preservation service model. Diabetes Care. 2005;28(2):248–53.CrossRefPubMedGoogle Scholar
  31. 31.
    Regensteiner JG, Wolfel EE, Brass EP, Carry MR, Ringel SP, Hargarten ME, et al. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation. 1993;87(2):413–21.CrossRefPubMedGoogle Scholar
  32. 32.
    American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333–41.CrossRefGoogle Scholar
  33. 33.
    Gloviczki P, Bower TC, Toomey BJ, Mendonca C, Naessens JM, Schabauer AM, et al. Microscope-aided pedal bypass is an effective and low-risk operation to salvage the ischemic foot. Am J Surg. 1994;168(2):76–84.CrossRefPubMedGoogle Scholar
  34. 34.
    LoGerfo FW, Gibbons GW, Pomposelli Jr FB, Campbell DR, Miller A, Freeman DV, et al. Trends in the care of the diabetic foot. Expanded role of arterial reconstruction. Arch Surg. 1992;127(5):617–20; discussion 20–1.CrossRefPubMedGoogle Scholar
  35. 35.
    Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2(3):221–6.CrossRefPubMedGoogle Scholar
  36. 36.
    VascularWeb. Endovascular training program endorsement essentials. 2007 [cited Dec 2007].
  37. 37.
    Prinssen M, Verhoeven EL, Buth J, Cuypers PW, van Sambeek MR, Balm R, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2004;351(16):1607–18.CrossRefPubMedGoogle Scholar
  38. 38.
    Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51 Suppl 5:5S–17.CrossRefPubMedGoogle Scholar
  39. 39.
    Andras A, Hansrani M, Stewart M, Stansby G. Intravascular brachytherapy for peripheral vascular disease. Cochrane Database Syst Rev. 2014;1, CD003504.Google Scholar
  40. 40.
    Kitrou P, Parthipun A, Diamantopoulos A, Padayachee S, Karunanithy N, Ahmed I, et al. Paclitaxel-coated balloons for failing peripheral bypass grafts: the BYPACS study. J Cardiovasc Surg (Torino). 2014;55(2):217–24.Google Scholar
  41. 41.
    McCaslin JE, Andras A, Stansby G. Cryoplasty for peripheral arterial disease. Cochrane Database Syst Rev. 2013;8, CD005507.Google Scholar
  42. 42.
    San Norberto EM, Taylor JH, Carrera S, Vaquero C. Percutaneous transluminal angioplasty with drug-eluting balloons for salvage of infrainguinal bypass grafts. J Endovasc Ther. 2014;21(1):12–21.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Sara B. Edwards
    • 1
  • Jennifer K. Svahn
    • 2
    Email author
  • Jeffrey S. Kirk
    • 3
  • Omar H. Llaguna
    • 4
  • Nancy A. Habib
    • 5
  1. 1.Department of SurgeryMount Sinai Beth IsraelNew YorkUSA
  2. 2.Division of Vascular Surgery, Department of SurgeryMount Sinai Beth IsraelNew YorkUSA
  3. 3.Division of Vascular Surgery, Department of SurgeryCapital Regional Medical CenterTallahasseeUSA
  4. 4.Department of Surgical OncologyBaptista Health SouthMiamiUSA
  5. 5.Department of DermatologyKaiser Permanente Southern CaliforniaLos AngelesUSA

Personalised recommendations